Publications (151,530)

Search

Structural and Functional Assessment of Human Ventricular Myocardium

Abu-Khousa M, Fiegle D, Dendorfer A, Volk T, Seidel T (2019)

Conference contribution

Effects of activin A on hippocampal network activity

Dahlmanns M, Dahlmanns J, Zheng F, Alzheimer C (2019)

Conference contribution

Activation of the protease-activated receptor type 2 (PAR2) has a sustained stimulatory effect on the epithelial sodium channel (ENaC) in mCCDcl1 mouse cortical collecting duct cells

Schmidt M, Korbmacher C, Bertog M (2019)

Conference contribution

Glucocorticoid signaling and modulation of autophagy is involved in the preservation of the cardiomyocyte t-tubular system

Fiegle D, Abu-Khousa M, Seidel T, Volk T (2019)

Conference contribution

Modulatory effects of apical and basolateral proteases on renal ENaC function

Bertog M, Korbmacher C (2019)

Conference contribution

Effects of syntaxin 2, 3, and 4 on rat and human epithelial sodium channel (ENaC) in Xenopus laevis oocytes

Rauh R, Frost F, Korbmacher C (2019)

Conference contribution

Next-generation DNA sequencing (NGS) results for tumours from phase II ABRAZO study of talazoparib after platinum or cytotoxic non-platinum regimens in patients (pts) with advanced breast cancer (ABC) and germline BRCA1/2 (gBRCA) mutations

Turner NC, Laird AD, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke EM, et al. (2019)

Conference contribution

Overall survival (OS) results of the phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR plus ), human epidermal growth factor 2-negative (HER2-) advanced breast cancer (ABC) treated with fulvestrant (FUL) (+) ribociclib (RIB)

Slamon DJ, Neven P, Chia S, Fasching P, De Laurentiis M, Im SA, Petrakova K, et al. (2019)

Conference contribution

KEYNOTE-522: Phase III study of pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo (pbo) plus chemo as neoadjuvant treatment, followed by pembro vs pbo as adjuvant treatment for early triple-negative breast cancer (TNBC)

Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur HL, Kuemmel S, Bergh J, et al. (2019)

Conference contribution

Chemotherapy (CT)-induced anaemia in patients (pts) treated with dose-dense regimen: Results of the prospectively randomised anaemia substudy from the neoadjuvant GeparOcto study

Tesch H, Loibl S, Kast K, Jackisch C, Moebus V, Buchen S, Untch M, et al. (2019)

Conference contribution

‹ 1 ... 5,170 5,171 5,172 5,173 5,174 ... 15,153 ›